Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derek Kennedy

Showing results (21-30 of 70) with videos related to

Pageof 7
Sort By:
Postgraduate Medical Journal|June 20, 2014
TLR9: an important molecule in the fight against hepatitis B virusAziz Shahrakyvahed, Javad Sanchooli, Nima Sanadgol, et al.
Clinical Laboratory|January 8, 2013
Occult hepatitis B virus (HBV) infection: a global challenge for medicineShokrollah Assar, Mohammad Kazemi Arababadi, Behzad Nasiri Ahmadabadi, et al.
Inflammation|September 9, 2011
The IL-10 promoter polymorphism at position -592 is correlated with susceptibility to occult HBV infectionBehzad Nasiri Ahmadabadi, Gholamhossein Hassanshahi, Mohammad Kazemi Arababadi, et al.
Life Sciences|July 5, 2016
The link between TLR7 signaling and hepatitis B virus infectionZahra Sepehri, Zohre Kiani, Seyed Moayed Alavian, et al.
Hepatitis Monthly|January 12, 2012
Post-transfusion occult hepatitis B (OBI): a global challenge for blood recipients and health authoritiesMohammad Kazemi Arababadi, Gholamhossein Hassanshahi, Ali Akbar Pourfathollah, et al.
Clinics and Research in Hepatology and Gastroenterology|February 26, 2013
Reduced expression of TRIF in chronic HBV infected Iranian patientsFatemeh Ayoobi, Gholamhossein Hassanshahi, Nahid Zainodini, et al.
Basic & Clinical Pharmacology & Toxicology|April 23, 2015
Ascorbic Acid Reduces the Adverse Effects of Delayed Administration of Tissue Plasminogen Activator in a Rat Stroke ModelMohammad Allahtavakoli, Fatemeh Amin, Ali Esmaeeli-Nadimi, et al.
Oncotarget|December 13, 2017
Sox2 modulates motility and enhances progression of colorectal cancer via the Rho-ROCK signaling pathwayJunheng Zheng, Lixiao Xu, Yubin Pan, et al.
Molecular and Cellular Biology|June 20, 2006
The redox state of SECIS binding protein 2 controls its localization and selenocysteine incorporation functionLaura V Papp, Jun Lu, Frank Striebel, et al.
Microbial Pathogenesis|April 2, 2014
TLR4 in Toxoplasmosis; friends or foe?Mohammad Zare-Bidaki, Hamid Hakimi, Seyyed Hossein Abdollahi, et al.
Pageof 7

Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Postgraduate Medical Journal|June 20, 2014
TLR9: an important molecule in the fight against hepatitis B virusAziz Shahrakyvahed, Javad Sanchooli, Nima Sanadgol, et al.
Clinical Laboratory|January 8, 2013
Occult hepatitis B virus (HBV) infection: a global challenge for medicineShokrollah Assar, Mohammad Kazemi Arababadi, Behzad Nasiri Ahmadabadi, et al.
Inflammation|September 9, 2011
The IL-10 promoter polymorphism at position -592 is correlated with susceptibility to occult HBV infectionBehzad Nasiri Ahmadabadi, Gholamhossein Hassanshahi, Mohammad Kazemi Arababadi, et al.
Life Sciences|July 5, 2016
The link between TLR7 signaling and hepatitis B virus infectionZahra Sepehri, Zohre Kiani, Seyed Moayed Alavian, et al.
Hepatitis Monthly|January 12, 2012
Post-transfusion occult hepatitis B (OBI): a global challenge for blood recipients and health authoritiesMohammad Kazemi Arababadi, Gholamhossein Hassanshahi, Ali Akbar Pourfathollah, et al.
Clinics and Research in Hepatology and Gastroenterology|February 26, 2013
Reduced expression of TRIF in chronic HBV infected Iranian patientsFatemeh Ayoobi, Gholamhossein Hassanshahi, Nahid Zainodini, et al.
Basic & Clinical Pharmacology & Toxicology|April 23, 2015
Ascorbic Acid Reduces the Adverse Effects of Delayed Administration of Tissue Plasminogen Activator in a Rat Stroke ModelMohammad Allahtavakoli, Fatemeh Amin, Ali Esmaeeli-Nadimi, et al.
Oncotarget|December 13, 2017
Sox2 modulates motility and enhances progression of colorectal cancer via the Rho-ROCK signaling pathwayJunheng Zheng, Lixiao Xu, Yubin Pan, et al.
Molecular and Cellular Biology|June 20, 2006
The redox state of SECIS binding protein 2 controls its localization and selenocysteine incorporation functionLaura V Papp, Jun Lu, Frank Striebel, et al.
Microbial Pathogenesis|April 2, 2014
TLR4 in Toxoplasmosis; friends or foe?Mohammad Zare-Bidaki, Hamid Hakimi, Seyyed Hossein Abdollahi, et al.
Pageof 7